Literature DB >> 16094723

Expression of interferon inducible protein-10 in pancreas of mice.

Dong Li1, Su-Wen Zhu, Dong-Juan Liu, Guo-Liang Liu.   

Abstract

AIM: To investigate the expression of interferon inducible protein-10 (IP-10) in pancreas of mice and to discuss its possible role in the pathogenesis of type 1 diabetes.
METHODS: Non-obese diabetic (NOD) mice were used as experiment group and BALB/c mice as non-diabetic prone model. Immunohistochemistry method was used to evaluate the expression of IP-10 in the pancreas of NOD mice and BALB/c mice. Immunoelectron microscope was used to show the location of IP-10 in pancreatic islet beta cells.
RESULTS: Pancreatic islets were positively stained in all the NOD mice. Insulitis could be found in mice at the age of 4 wk. The weakly positive results were found in control group with no insulitis. Immunoelectron microscopy further demonstrated that IP-10 was produced by pancreatic beta cells and stored in cytoplasm of the cells.
CONCLUSION: IP-10 can be largely produced in pancreatic islets of NOD mice at the age of 2 wk when there is no significant insulitis, and may play an important part in the pathogenesis of type 1 diabetes by attracting immune cells to infiltrate the pancreatic islets.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16094723      PMCID: PMC4615424          DOI: 10.3748/wjg.v11.i30.4750

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  8 in total

Review 1.  Chemokines in autoimmune diseases.

Authors:  S Arimilli; W Ferlin; N Solvason; S Deshpande; M Howard; S Mocci
Journal:  Immunol Rev       Date:  2000-10       Impact factor: 12.988

2.  Fatal attraction: chemokines and type 1 diabetes.

Authors:  Mark A Atkinson; S Brian Wilson
Journal:  J Clin Invest       Date:  2002-12       Impact factor: 14.808

Review 3.  Type 1 diabetes: recent developments.

Authors:  Devasenan Devendra; Edwin Liu; George S Eisenbarth
Journal:  BMJ       Date:  2004-03-27

Review 4.  Type 1 diabetes: new perspectives on disease pathogenesis and treatment.

Authors:  M A Atkinson; G S Eisenbarth
Journal:  Lancet       Date:  2001-07-21       Impact factor: 79.321

5.  IL-1beta and IFN-gamma induce the expression of diverse chemokines and IL-15 in human and rat pancreatic islet cells, and in islets from pre-diabetic NOD mice.

Authors:  A K Cardozo; P Proost; C Gysemans; M-C Chen; C Mathieu; D L Eizirik
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

6.  Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes.

Authors:  L M Bradley; V C Asensio; L K Schioetz; J Harbertson; T Krahl; G Patstone; N Woolf; I L Campbell; N Sarvetnick
Journal:  J Immunol       Date:  1999-03-01       Impact factor: 5.422

7.  Double-stranded RNA cooperates with interferon-gamma and IL-1 beta to induce both chemokine expression and nuclear factor-kappa B-dependent apoptosis in pancreatic beta-cells: potential mechanisms for viral-induced insulitis and beta-cell death in type 1 diabetes mellitus.

Authors:  Dongbo Liu; Alessandra K Cardozo; Martine I Darville; Décio L Eizirik
Journal:  Endocrinology       Date:  2002-04       Impact factor: 4.736

8.  Elevated serum IP-10 levels observed in type 1 diabetes.

Authors:  A Shimada; J Morimoto; K Kodama; R Suzuki; Y Oikawa; O Funae; A Kasuga; T Saruta; S Narumi
Journal:  Diabetes Care       Date:  2001-03       Impact factor: 19.112

  8 in total
  2 in total

1.  Cathepsin C Regulates Cytokine-Induced Apoptosis in β-Cell Model Systems.

Authors:  Tina Fløyel; Caroline Frørup; Joachim Størling; Flemming Pociot
Journal:  Genes (Basel)       Date:  2021-10-25       Impact factor: 4.096

2.  Pro-inflammatory β cell small extracellular vesicles induce β cell failure through activation of the CXCL10/CXCR3 axis in diabetes.

Authors:  Naureen Javeed; Tracy K Her; Matthew R Brown; Patrick Vanderboom; Kuntol Rakshit; Aoife M Egan; Adrian Vella; Ian Lanza; Aleksey V Matveyenko
Journal:  Cell Rep       Date:  2021-08-24       Impact factor: 9.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.